Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Sanofi

02 2AstraZeneca

03 5GSK

04 1Panacea Biotec Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Sweden

Haemophilus influenzae type B polysaccharide

Brand Name : Act-HIB

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

02

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

HAEMOPHILUS INFLUENZAE TYPE B-PRP

Brand Name : ACT-HIB

Dosage Form : KIT

Dosage Strength : 10MCG/0.5ML

Packaging : 5X1VIAL - 5X0.5ML AMP

Approval Date :

Application Number : 1959034

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

03

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

HAEMOPHILUS INFLUENZAE TYPE B-PRP

Brand Name : PEDIACEL

Dosage Form : SUSPENSION

Dosage Strength : 10MCG/0.5ML

Packaging : 5X0.5ML

Approval Date :

Application Number : 2243167

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

04

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

HAEMOPHILUS INFLUENZAE TYPE B-PRP

Brand Name : PENTACEL

Dosage Form : SUSPENSION

Dosage Strength : 10MCG/0.5ML

Packaging :

Approval Date :

Application Number : 2534797

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

05

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Haemophilus influenzae type b

Brand Name : Pentaxim ®

Dosage Form : INJ

Dosage Strength : 10mcg

Packaging : 0.5X1IU

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

06

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Haemophilus influenzae type b polysaccharide, conjugated to tetanus protein [tetanus protein: 22 – 36  µg]

Brand Name : Hexaxim ®

Dosage Form : INJ

Dosage Strength : 12µg/0.5ml

Packaging : 0.5X1IU/5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

07

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Haemophilus influenzae type b

Brand Name : Hexaxim ®

Dosage Form : INJ

Dosage Strength : 12µg/0.5ml

Packaging : 0.5X10IU/0.5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

08

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Hemophilus influenzae B, combinations with toxoids

Brand Name : Act-HIB

Dosage Form : VAC

Dosage Strength : 10mcg

Packaging : 1X1mcg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

09

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Hemophilus influenzae B, combinations with toxoids

Brand Name : CombAct-HIB

Dosage Form : VAC

Dosage Strength : 10mcg

Packaging : 1X1mcg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

10

arrow
The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Hemophilus influenzae B, combinations with toxoids

Brand Name : CombAct-HIB

Dosage Form : VAC

Dosage Strength : 10mcg

Packaging : 1X1mcg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

11

The Pharmacy Technology
Not Confirmed
arrow
arrow
The Pharmacy Technology
Not Confirmed

INFLUENZA VIRUS TYPE B (VICTORIA)

Brand Name : FLUMIST QUADRIVALENT

Dosage Form : SPRAY

Dosage Strength : 32000000FFU/0.2ML

Packaging :

Approval Date :

Application Number : 2426544

Regulatory Info : Schedule D

Registration Country : Canada

blank

12

The Pharmacy Technology
Not Confirmed
arrow
arrow
The Pharmacy Technology
Not Confirmed

INFLUENZA VIRUS TYPE B (YAMAGATA)

Brand Name : FLUMIST QUADRIVALENT

Dosage Form : SPRAY

Dosage Strength : 32000000FFU/0.2ML

Packaging :

Approval Date :

Application Number : 2426544

Regulatory Info : Schedule D

Registration Country : Canada

blank

13

The Pharmacy Technology
Not Confirmed
arrow
arrow
The Pharmacy Technology
Not Confirmed

Haemophilus influenzae typ B polysackarid

Brand Name : Hiberix

Dosage Form : PULVER OCH VÄTSKA TILL INJEKTIONSVÄTSKA

Dosage Strength : --

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

14

The Pharmacy Technology
Not Confirmed
arrow
arrow
The Pharmacy Technology
Not Confirmed

HAEMOPHILUS INFLUENZAE TYPE B-PRP

Brand Name : INFANRIX HEXA

Dosage Form : SUSPENSION

Dosage Strength : 10MCG/0.5ML

Packaging : 10X0.5ML

Approval Date :

Application Number : 2253852

Regulatory Info : Schedule D

Registration Country : Canada

blank

15

The Pharmacy Technology
Not Confirmed
arrow
arrow
The Pharmacy Technology
Not Confirmed

Haemophilus Influenza Type B: PRP

Brand Name : Rotarix Oral Vaccine

Dosage Form : POW

Dosage Strength : 10ug/0.5ml

Packaging : 1X1CCID 50/dose

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

16

The Pharmacy Technology
Not Confirmed
arrow
arrow
The Pharmacy Technology
Not Confirmed

Haemophilus Influenza Type B: T

Brand Name : Rotarix Oral Vaccine

Dosage Form : POW

Dosage Strength : 40ug/0.5ml

Packaging : 1X1CCID 50/dose

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

17

The Pharmacy Technology
Not Confirmed
arrow
arrow
The Pharmacy Technology
Not Confirmed

Hemophilus influenzae b

Brand Name : Hiberix

Dosage Form : VAC

Dosage Strength : 10mcg/0.5ml

Packaging : 3X1mcg/0.5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

18

The Pharmacy Technology
Not Confirmed
arrow
arrow
The Pharmacy Technology
Not Confirmed

Haemophilus Influenzae Type b

Brand Name :

Dosage Form : Vaccine

Dosage Strength :

Packaging : PFS/Vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank